Obesity and stroke: Can we translate from rodents to patients?

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 12, 2016, Pages 2007-2021

  Haley, Michael J ^a   Lawrence, Catherine B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

adiposity; blood brain barrier; inflammation; Obesity; stroke

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; COMORBIDITY; EXPERIMENTAL STROKE; HUMAN; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; ANIMAL; COMPLICATION; INFLAMMATION; MORTALITY; RODENT; STANDARDS; STROKE; TRANSLATIONAL RESEARCH;

ANIMALS; HUMANS; INFLAMMATION; OBESITY; RODENTIA; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85001946096     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16670411     Document Type: Review

References (157)

1. Flegal KM, Kit BK, Orpana H, et al. Association of allcause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-Analysis. JAMA 2013; 309: 71-82.
2. Heuschmann PU, Kircher J, Nowe T, et al. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey. Eur J Prev Cardiol 2015; 22: 1354-1362.
3. Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe: epidemiological update. Eur Heart J 2013; 34: 3028-3034.
4. Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35: 2950-2959.
5. Strazzullo P, D?Elia L, Cairella G, et al. Excess body weight and incidence of stroke: Meta-Analysis of prospective studies with 2 million participants. Stroke 2010; 41: e418-e426.
6. Ni Mhurchu C, Rodgers A, Pan WH, et al. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 2004; 33: 751-758.
7. Rexrode KM, Hennekens CH, Willett WC, et al A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277: 1539-1545.
8. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002; 162: 2557-2562.
9. Song YM. Body mass index and ischemic and hemorrhagic stroke: A prospective study in Korean men. Stroke 2004; 35: 831-836.
10. Park JW, Lee S-Y, Kim SY, et al. BMI and stroke risk in Korean women. Obesity 2008; 16: 396-401.
11. Lu M, Ye W, Adami HO, et al. Prospective study of body size and risk for stroke amongst women below age 60. J Int Med 2006; 260: 442-450.
12. Jood K, Jern C, Wilhelmsen L, et al. Body mass index in mid-life is associated with a first stroke in men: A prospective population study over 28 years. Stroke 2004; 35: 2764-2769.
13. Kurth T. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005; 111: 1992-1998.
14. Hu G, Tuomilehto J, Silventoinen K, et al. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007; 167: 1420-1427.
15. Cheng NT, and Kim AS. Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. Neurohospitalist 2015; 5: 101-109.
16. Deguchi I, Ohe Y, Fukuoka T, et al. Relationship of obesity to recanalization after hyperacute recombinant tissue-plasminogen activator infusion therapy in patients with middle cerebral artery occlusion. J Stroke Cerebrovasc Dis 2012; 21: 161-164.
17. Dorado L, Arenillas JF, López-Cancio E, et al. Metabolic syndrome predicts refractoriness to intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis 2015; 24: 2605-2612.
18. Arenillas JF, Sandoval P, Perez de la Ossa N, et al. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men. Stroke 2009; 40: 344-349.
19. Brott TG, Haley EC, Levy DE, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23: 632-640.
20. Lou M, and Selim M. Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients?. Cerebrovasc Dis 2009; 27: 84-90.
21. Sarikaya H, Arnold M, Engelter ST, et al. Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg. Cerebrovasc Dis 2011; 32: 201-206.
22. Murray KN, Buggey HF, Denes A, et al. Systemic immune activation shapes stroke outcome. Mol Cell Neurosci 2013; 53: 14-25.
23. Smith CJ, Lawrence CB, Rodriguez-Grande B, et al. The immune system in stroke: clinical challenges and their translation to experimental research. J Neuroimmune Pharmacol 2013; 8: 867-887.
24. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
25. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
26. Herder C, Schneitler S, Rathmann W, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 2007; 92: 4569-4574.
27. Rexrode KM, Pradhan A, Manson JE, et al. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 2003; 13: 674-682.
28. Khaodhiar L, Ling P-R, Blackburn GL, et al. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 2004; 28: 410-415.
29. Maachi M, Piéroni L, Bruckert E, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28: 993-997.
30. Kim C-S, Park HS, Kawada T, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 2006; 30: 1347-1355.
31. Thompson AM, Zhang Y, Tong W, et al. Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int J Cardiol 2011; 150: 247-252.
32. Guri AJ, and Bassaganya-Riera J. Systemic effects of white adipose tissue dysregulation and obesity-related inflammation. Obesity (Silver Spring) 2011; 19: 689-700.
33. Trayhurn P, and Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33: 1078-1081.
34. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32: 2575-2579.
35. Miwa K, Tanaka M, Okazaki S, et al. Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors. Arterioscler Thromb Vasc Biol 2013; 33: 400-405.
36. Ofstad AP, Gullestad L, Orvik E, et al. Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study. Cardiovasc Diabetol 2013; 12: 126.
37. Patterson CC, Smith AE, Yarnell JWG, et al. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study. Atherosclerosis 2010; 209: 551-557.
38. Seven E, Husemoen LLN, Sehested TSG, et al. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study. PLoS One 2015; 10: e0128987.
39. Olsen TSOJ, Dehlendorff C, Petersen HG, et al. Body mass index and poststroke mortality. Neuroepidemiology 2008; 30: 93-100.
40. Vemmos K, Ntaios G, Spengos K, et al. Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011; 42: 30-36.
41. Kim BJ, Lee SH, Jung KH, et al. Dynamics of obesity paradox after stroke, related to time from onset, age, and causes of death. Neurology 2012; 79: 856-863.
42. Doehner W, Schenkel J, Anker SD, et al. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J 2013; 34: 268-277.
43. Skolarus LE, Sanchez BN, Levine DA, et al. Association of body mass index and mortality after acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2014; 7: 64-69.
44. Andersen KK, and Olsen TS. The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke 2015; 10: 99-104.
45. Kazemi-Bajestani SMR, Ghayour-Mobarhan M, Thrift AG, et al. Obesity paradox versus frailty syndrome in first-ever ischemic stroke survivors. Int J Stroke 2015; 10: E75-E75.
46. Wohlfahrt P, Lopez-Jimenez F, Krajcoviechova A, et al. The obesity paradox and survivors of ischemic stroke. J Stroke Cerebrovasc Dis 2015; 24: 1443-1450.
47. Towfighi A, and Ovbiagele B. The impact of body mass index on mortality after stroke. Stroke 2009; 40: 2704-2708.
48. Barba R, Marco J, Ruiz J, et al. The obesity paradox in stroke: impact on mortality and short-Term readmission. J Stroke Cerebrovasc Dis 2015; 24: 766-770.
49. Nishioka S, Wakabayashi H, Yoshida T, et al. Obese Japanese patients with stroke have higher functional recovery in convalescent rehabilitation wards: A retrospective cohort study. J Stroke Cerebrovasc Dis 2016; 25: 26-33.
50. Hassan AE, Chaudhry SA, Jani V, et al. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?. J Stroke Cerebrovasc Dis 2013; 22: 545-549.
51. Ryu W-S, Lee S-H, Kim CK, et al. Body mass index, initial neurological severity and long-Term mortality in ischemic stroke. Cerebrovasc Dis 2011; 32: 170-176.
52. Kim Y, Kim CK, Jung S, et al. Obesity-stroke paradox and initial neurological severity. J Neurol Neurosurg Psychiatry 2015; 86: 743-747.
53. Dehlendorff C, Andersen KK, and Olsen TS. Body mass index and death by stroke: no obesity paradox. JAMA Neurol 2014; 71: 978-984.
54. Katsnelson M, and Rundek T. Obesity paradox and stroke: noticing the (fat) man behind the curtain. Stroke 2011; 42: 3331-3332.
55. DoehnerWand Audebert HJ. The impact of body weight on mortality after stroke: the controversy continues. JAMA Neurol 2015; 72: 126-127.
56. Brzecka A, and Ejma M. Obesity paradox in the course of cerebrovascular diseases. Adv Clin Exp Med 2015; 24: 379-383.
57. Haley MJ, and Lawrence CB. The blood-brain barrier after stroke: Structural studies and the role of transcytotic vesicles. J Cereb Blood Flow Metab. Epub ahead of print 28 January 2016. DOI: 10.1177/0271678X16629976.
58. Cao X-L, Du J, Zhang Y, et al. Hyperlipidemia exacerbates cerebral injury through oxidative stress, inflammation and neuronal apoptosis in MCAO/reperfusion rats. Exp Brain Res 2015; 233: 2753-2765.
59. Deng J, Xiong L, and Zuo Z. Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice. J Neurosci Res 2015; 93: 615-622.
60. Maysami S, Haley MJ, Gorenkova N, et al. Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after stroke. J Neuroinflamm 2015; 12: 1-12.
61. Wu M-H, Chio C-C, Tsai K-J, et al. Obesity exacerbates rat cerebral ischemic injury through enhancing ischemic adiponectin-containing neuronal apoptosis. Mol Neurobiol 2016; 53: 3702-3713.
62. Cheon SH, Yan BC, Chen BH, et al. Accelerated and exacerbated effects of high dietary fat on neuronal damage induced by transient cerebral ischemia in the gerbil septum. Endocrinol Metab (Seoul) 2014; 29: 328-335.
63. Yan BC, Park JH, Ahn JH, et al. Effects of high-fat diet on neuronal damage, gliosis, inflammatory process and oxidative stress in the hippocampus induced by transient cerebral ischemia. Neurochem Res 2014; 39: 2465-2478.
64. Deng J, Zhang J, Feng C, et al. Critical role of matrix metalloprotease-9 in chronic high fat diet-induced cerebral vascular remodelling and increase of ischaemic brain injury in mice. Cardiovasc Res 2014; 103: 473-484.
65. Yang Z, Chen Y, Zhang Y, et al. Sevoflurane postconditioning against cerebral ischemic neuronal injury is abolished in diet-induced obesity: role of brain mitochondrial KATP channels. Mol Med Rep 2014; 9: 843-850.
66. Kim E, Tolhurst AT, and Cho S. Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury. J Neuroinflamm 2014; 11: 83.
67. Herz J, Hagen SI, Bergmüller E, et al. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis 2014; 62: 456-468.
68. Dhungana H, Rolova T, Savchenko E, et al. Westerntype diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele. J Neuroinflamm 2013; 10: 1-1.
69. Kim E, Febbraio M, Bao Y, et al. CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. Ann Neurol 2012; 71: 753-764.
70. Pradillo JM, Denes A, Greenhalgh AD, et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J Cereb Blood Flow Metab 2012; 32: 1810-1819.
71. Kawai H, Deguchi S, Deguchi K, et al. Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat. Brain Res 2011; 1382: 308-314.
72. Kawai H, Deguchi S, Deguchi K, et al. Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat. Brain Res 2011; 1368: 317-323.
73. Langdon KD, Clarke J, and Corbett D. Long-Term exposure to high fat diet is bad for your brain: exacerbation of focal ischemic brain injury. Neuroscience 2011; 182: 82-87.
74. Kumari R, Willing LB, Patel SD, et al. Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke. J Neurochem 2011; 119: 1029-1040.
75. Tureyen K, Bowen K, Liang J, et al. Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. J Neurochem 2011; 116: 499-507.
76. Ritter L, Davidson L, Henry M, et al. Exaggerated neutrophil-mediated reperfusion injury after ischemic stroke in a rodent model of type 2 diabetes. Microcirculation 2011; 18: 552-561.
77. Chen J, Cui X, Zacharek A, et al. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke 2011; 42: 445-452.
78. Kumari R, Willing LB, Patel SD, et al. The PPARgamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. J Cereb Blood Flow Metab 2010; 30: 352-360.
79. Osmond JM, Mintz JD, and Stepp DW. Preventing increased blood pressure in the obese Zucker rat improves severity of stroke. AJP: Heart Circ Physiol 2010; 299: H55-H61.
80. McColl BW, Rose N, Robson FH, et al. Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke. J Cereb Blood Flow Metab 2010; 30: 267-272.
81. Arvanitidis AP, Corbett D, and Colbourne F A high fat diet does not exacerbate CA1 injury and cognitive deficits following global ischemia in rats. Brain Res 2009; 1252: 192-200.
82. Deutsch C, Portik-Dobos V, Smith AD, et al. Dietinduced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res 2009; 78: 100-106.
83. Osmond JM, Mintz JD, Dalton B, et al. Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension 2009; 53: 381-386.
84. Valerio A, Dossena M, Bertolotti P, et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription. Stroke 2009; 40: 610-617.
85. Kim E, Tolhurst AT, Qin LY, et al. CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury. J Neurosci 2008; 28: 4661-4670.
86. Terao S, Yilmaz G, Stokes KY, et al. Inflammatory and Injury Responses to Ischemic Stroke in Obese Mice. Stroke 2008; 39: 943-950.
87. Mayanagi K, Katakam PV, Gáspár T, et al. Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 1927-1935.
88. Nagai N, Van Hoef B, and Lijnen HR. Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice. J Thromb Haemost 2007; 5: 1726-1731.
89. Tureyen K, Kapadia R, Bowen KK, et al. Peroxisome proliferator-Activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 2007; 101: 41-56.
90. Kumari R, Willing LB, Krady JK, et al. Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J Cereb Blood Flow Metab 2007; 27: 710-718.
91. Zhang L, Nair A, Krady K, et al. Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J Clin Invest 2004; 113: 85-95.
92. Vannucci SJ, Willing LB, Goto S, et al. Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab 2001; 21: 52-60.
93. Li W, Prakash R, Chawla D, et al. Early effects of highfat diet on neurovascular function and focal ischemic brain injury. Am J Physiol Regul Integr Comp Physiol 2013; 304: R1001-R1008.
94. Park S, Kim Da Sol, Kang S, et al. Ischemic hippocampal cell death induces glucose dysregulation by attenuating glucose-stimulated insulin secretion which is exacerbated by a high fat diet. Life Sci 2011; 88: 766-773.
95. Lorberboym M, Lampl Y, and Sadeh M. Correlation of 99mTc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke. J Nucl Med 2003; 44: 1898-1904.
96. Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008; 39: 2249-2256.
97. Brouns R, Wauters A, De Surgeloose D, et al. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol 2011; 65: 23-31.
98. Alvarez-Sabin J, Maisterra O, Santamarina E, et al. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 2013; 12: 689-705.
99. Vachharajani V, Russell JM, Scott KL, et al. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 2005; 12: 183-194.
100. Pistell PJ, Morrison CD, Gupta S, et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 2010; 219: 25-32.
101. Nerurkar PV, Johns LM, Buesa LM, et al. Momordica charantia (bitter melon) attenuates high-fat dietassociated oxidative stress and neuroinflammation. J Neuroinflamm 2011; 8: 64.
102. Thaler JP, Yi C-X, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 2012; 122: 153-162.
103. Knight EM, Martins IVA, Gümüsgöz S, et al. High-fat diet-induced memory impairment in triple-Transgenic Alzheimer?s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging 2014; 35: 1821-1832.
104. Cai D. Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab 2013; 24: 40-47.
105. Offner H, Subramanian S, Parker SM, et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006; 26: 654-665.
106. Chapman KZ, Dale VQ, Denes A, et al A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 2009; 29: 1764-1768.
107. Denes A, McColl BW, Leow-Dyke SF, et al. Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J Cereb Blood Flow Metab 2011; 31: 1036-1050.
108. Gidday JM, Gasche YG, Copin J-C, et al. Leukocytederived matrix metalloproteinase-9 mediates bloodbrain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. AJP: Heart Circ Physiol 2005; 289: H558-68.
109. Nieman DC, Henson DA, Nehlsen-Cannarella SL, et al. Influence of obesity on immune function. J Am Diet Assoc 1999; 99: 294-299.
110. Kullo IJ, Hensrud DD, and Allison TG. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (25, 25 to 30, or ?30. Am J Cardiol. 2002 89 1441-1443.
111. Dixon JB and O?Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg 2006; 16: 251-257.
112. Herishanu Y, Rogowski O, Polliack A, et al. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 2006; 76: 516-520.
113. Nijhuis J, Rensen SS, Slaats Y, et al. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity 2009; 17: 2014-2018.
114. Trottier MD, Naaz A, Kacynski K, et al. Functional capacity of neutrophils from class III obese patients. Obesity (Silver Spring) 2012; 20: 1057-1065.
115. Trottier MD, Naaz A, Li Y, et al. Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proc Natl Acad Sci USA 2012; 109: 7622-7629.
116. Kim CK, Ryu W-S, Kim BJ, et al. Paradoxical effect of obesity on hemorrhagic transformation after acute ischemic stroke. BMC Neurol 2013; 13: 123.
117. Sarikaya H, Elmas F, Arnold M, et al. Impact of obesity on stroke outcome after intravenous thrombolysis. Stroke 2011; 42: 2330-2332.
118. Seet RCS, Zhang Y, Wijdicks EFM, et al. Thrombolysis outcomes among obese and overweight stroke patients: an age- And National Institutes of Health Stroke Scalematched comparison. J Stroke Cerebrovasc Dis 2014; 23: 1-6.
119. Suzuki M, Yamamoto D, Suzuki T, et al. High fat and high fructose diet induced intracranial atherosclerosis and enhanced vasoconstrictor responses in non-human primate. Life Sci 2006; 80: 200-204.
120. Tucsek Z, Toth P, Tarantini S, et al. Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice. J Gerontol A Biol Sci Med Sci 2014; 69: 1339-1352.
121. Czernichow S, Bertrais S, Blacher J, et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure A report from the SU.VI.MAX. Vascular Study. Am J Hypertens 2005; 18: 1154-1160.
122. Lind L, Siegbahn A, Ingelsson E, et al A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol 2011; 31: e27-e34.
123. Weil BR, Westby CM, Van Guilder GP, et al. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol 2011; 301: H689-H695.
124. Campia U, Tesauro M, and Cardillo C. Human obesity and endothelium-dependent responsiveness. Br J Pharmacol 2012; 165: 561-573.
125. Selim M, Jones R, Novak P, et al. The effects of body mass index on cerebral blood flow velocity. Clin Auton Res 2008; 18: 331-338.
126. Willeumier KC, Taylor DV, and Amen DG. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity (Silver Spring) 2011; 19: 1095-1097.
127. Birdsill AC, Carlsson CM, Willette AA, et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring) 2013; 21: 1313-1320.
128. Halberg N, Schraw TD, Wang ZV, et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 2009; 58: 1961-1970.
129. Maury E, and Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314: 1-16.
130. Nishimura M, Izumiya Y, Higuchi A, et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008; 117: 216-223.
131. Chen B, Liao W-Q, Xu N, et al. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 2009; 1273: 129-137.
132. Efstathiou SP, Tsioulos DI, Tsiakou AG, et al. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005; 36: 1915-1919.
133. Yatomi K, Miyamoto N, Komine-Kobayashi M, et al. Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain. Brain Res 2009; 1297: 169-176.
134. Spranger J, Verma S, Göhring I, et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006; 55: 141-147.
135. Lam KSL and Xu A. Adiponectin: protection of the endothelium. Curr Diab Rep 2005; 5: 254-259.
136. Morris DL, and Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009; 297: E1247-E1259.
137. Zhang F, Wang S, Signore AP, et al. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 2007; 38: 2329-2336.
138. Air EL, and Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care 2007; 30: 3131-3140.
139. Ergul A, Elgebaly MM, Middlemore M-L, et al. Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol 2007; 7: 33.
140. Veglio F, Paglieri C, Rabbia F, et al. Hypertension and cerebrovascular damage. Atherosclerosis 2009; 205: 331-341.
141. Balistreri CR, Caruso C, and Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediat Inflamm 2010; 2010: 19.
142. Shafrir E, and Ziv E A useful list of spontaneously arising animal models of obesity and diabetes. AJP: Endocrinol Metab 2009; 296: E1450-E1452.
143. Hariri N, and Thibault L. High-fat diet-induced obesity in animal models. Nutr Res Rev 2010; 23: 270-299.
144. Ergul A, Li W, Elgebaly MM, et al. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol 2009; 51: 44-49.
145. Scherbakov N, Dirnagl U, and Doehner W. Body weight after stroke: Lessons from the obesity paradox. Stroke 2011; 42: 3646-3650.
146. Sharp FR, and Jickling GC. Modeling immunity and inflammation in stroke: differences between rodents and humans?. Stroke 2014; 45: e179-e180.
147. Becker KJ. Strain-related differences in the immune response: Relevance to human stroke. Transl Stroke Res 2016; 7: 303-312.
148. Matarese G, Moschos S, and Mantzoros CS. Leptin in immunology. J Immunol 2005; 174: 3137-3142.
149. Farooqi IS and O?Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol 2014; 223: T63-T70.
150. Ferreira I, and Stehouwer CDA. Obesity paradox or inappropriate study designs?. Time for life-course epidemiology. J Hypertens 2012; 30: 2271-2275.
151. Banack HR, and Kaufman JS. Does selection bias explain the obesity paradox among individuals with cardiovascular disease?. Ann Epidemiol 2015; 25: 342-349.
152. Sperrin M, Candlish J, Badrick E, et al. Collider bias is only a partial explanation for the obesity paradox. Epidemiology 2016; 27: 525-530.
153. Alexopoulos N, Katritsis D, and Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis 2014; 233: 104-112.
154. Patel P, and Abate N. Body fat distribution and insulin resistance. Nutrients 2013; 5: 2019-2027.
155. Dallongeville J, Bhatt DL, Steg PG, et al. Relation between body mass index, waist circumference, and cardiovascular outcomes in 19, 579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol 2012; 19: 241-249.
156. Oliveros E, Somers VK, Sochor O, et al. The concept of normal weight obesity. Prog Cardiovasc Dis 2014; 56: 426-433.
157. Oreopoulos A, Ezekowitz JA, McAlister FA, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010; 85: 609-617.